Home LiteratureArticle Details
PMID: 16540390 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells.

Free radical biology & medicine ·Vol. 40 ·No. 6 ·2006-03-15 ·Pages 952-9

Kelley EE, Hock T, Khoo NK, Richardson GR, Johnson KK, Powell PC, Giles GI, Agarwal A, Lancaster JR, Tarpey MM

Abstract

Xanthine oxidoreductase (XOR) activity has been previously noted to be responsive to changes in O2 tension. While prior studies have focused on the extremes (0-3% and 95-100%) of O2 tensions, we report the influence of 10% O2 on endothelial cell XOR, a concentration resembling modest arterial hypoxia commonly found in patients with chronic cardiopulmonary diseases. Exposure of bovine aortic endothelial cells to 10% O2 increased XOR mRNA and protein abundance by 50%. Concomitantly, there was a 3-fold increase in XOR activity, XOR-dependent reactive oxygen species production, and cellular export of active enzyme. Although increases in mRNA and immunoreactive protein levels were observed, inhibition of transcription, translation, or protein degradation did not significantly alter cellular XOR specific activity, suggesting only modest contributions to 10% O2-induced effects. Exposure to 10% O2 did not increase cellular HIF-1alpha protein levels and hypoxia mimics did not alter XOR activity. Treatment of control cells with adenosine resulted in increased XOR activity similar to hypoxia. Exposure to the adenosine receptor agonist NECA increased enzymatic activity 4-fold while 8SPT, an adenosine receptor antagonist, reduced hypoxic induction of XOR activity approximately 50%. Combined, these data reveal that moderate hypoxia significantly enhances endothelial XOR specific activity, release, and XOR-derived reactive oxygen species generation. These effects appear to be mediated in part via adenosine-dependent processes.

MeSH Terms
Adenine/analogs & derivatives,pharmacology Adenosine/pharmacology Adenosine-5'-(N-ethylcarboxamide)/pharmacology Animals Aorta/cytology Cattle Endothelium, Vascular/cytology,enzymology Enzyme Induction Hypoxia/enzymology,physiopathology Hypoxia-Inducible Factor 1, alpha Subunit/pharmacology Oxygen/pharmacology Purinergic P1 Receptor Antagonists Reactive Oxygen Species/metabolism Xanthine Oxidase/metabolism
Chemicals
Hypoxia-Inducible Factor 1, alpha Subunit Purinergic P1 Receptor Antagonists Reactive Oxygen Species Adenosine-5'-(N-ethylcarboxamide) 9-(2-hydroxy-3-nonyl)adenine Xanthine Oxidase Adenine Adenosine Oxygen
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Kelley Eric E
Department of Anesthesiology, University of Alabama at Birmingham, AL 35233, USA. [email protected]
Hock Thomas
Khoo Nicholas K H
Richardson Gloria R
Johnson Kamorris K
Powell Pamela C
Giles Gregory I
Agarwal Anupam
Lancaster Jack R
Tarpey Margaret M
Article Info
Journal
Free radical biology & medicine
Abbr.
Free Radic Biol Med
ISSN
0891-5849
Published
2006-03-15
Epub
2005-00-01
Pages
952-9
Language
English
Region
United States
NLM ID
8709159
Subset
IM
Grants
NHLBI NIH HHS · R01 HL068157 · United States
NHLBI NIH HHS · R01 HL074391 · United States
NHLBI NIH HHS · R01 HL66110 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]